About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...

An instructional video regarding two stroke-related mnemonics was linked to faster 911 call response for suspected stroke, ...

A prehospital blood test may rapidly distinguish between ischemic and hemorrhagic strokes, potentially enabling more timely, ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

The challenges of translating neuroprotective interventions with promising efficacy in animal studies into effective treatments for patients with stroke are well documented, with issues including ...

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in P ...

It also caused by some poor lifestyle habits, such as increase in the use of Tobacco, low physical activity and diets high in fats and cholesterol. To recognise the signs of the stroke, a helpful ...

Adam Binns, an avid rock climber, unexpectedly suffered a severe stroke in January. Picture: Supplied Adam Binns (second from left) was sick while in Moonta when he suffered a stroke. Picture ...

It is a serious condition that is a major cause of heart attack and stroke worldwide. By 2025, it is estimated that 1.56 billion people globally will be diagnosed with high blood pressure. Things that ...

Prehospital measurement of glial fibrillary acidic protein (GFAP) can rapidly differentiate intracerebral hemorrhage (ICH) from ischemic stroke (IS) and stroke mimics.

Sugar-sweetened beverages, the epidemiology of driving after an ICD, BP measurements, and massive EBM lesson in EVT for acute stroke are the topics John Mandrola, MD, discusses in today's podcast.